title: Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.
abstract: TAFRO syndrome have been proposed as a rare variant of Castleman's disease. This article reports a case of a 56-year-old man with TAFRO syndrome who was successfully treated with thalidomide in spite of the refractoriness to prednisolone and tocilizumab. Thalidomide may be one of the treatment options for TAFRO syndrome.
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine Kyoto, Japan ; Division of Hematology and Oncology, JA Aichi Konan Kosei Hospital Aichi, Japan.
authors.forename: Shotaro
authors.initials: S
authors.lastname: Tatekawa
authors.affiliation: Division of Hematology and Oncology, JA Aichi Konan Kosei Hospital Aichi, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Umemura
authors.affiliation: Department of Diagnostic Pathology, JA Aichi Konan Kosei Hospital Aichi, Japan.
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Fukuyama
authors.affiliation: Division of Hematology and Oncology, JA Aichi Konan Kosei Hospital Aichi, Japan.
authors.forename: Akio
authors.initials: A
authors.lastname: Kohno
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine Kyoto, Japan.
authors.forename: Masafumi
authors.initials: M
authors.lastname: Taniwaki
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine Kyoto, Japan.
authors.forename: Junya
authors.initials: J
authors.lastname: Kuroda
authors.affiliation: Division of Hematology and Oncology, JA Aichi Konan Kosei Hospital Aichi, Japan.
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Morishita
keywords: Castleman's disease; Interleukin-6; TAFRO syndrome; thalidomide; tocilizumab; vascular endothelial growth factor